BIOGEN INC. Basic Shares Outstanding (Weighted Average)
BIOGEN INC. (BIIB) reported Basic Shares Outstanding (Weighted Average) of 147.20 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-04-29
- BIOGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 147.20M shares, a 0.75% increase year-over-year.
- BIOGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 146.80M shares, a 0.62% increase year-over-year.
- BIOGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 146.60M shares, a 0.62% increase year-over-year.
- BIOGEN INC. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 146.50M shares, a 0.62% increase year-over-year.
- BIOGEN INC. weighted average number of shares outstanding, basic for fiscal 2025 was 146.50M shares, a 0.62% increase from fiscal 2024.
- BIOGEN INC. weighted average number of shares outstanding, basic for fiscal 2024 was 145.60M shares, a 0.62% increase from fiscal 2023.
- BIOGEN INC. weighted average number of shares outstanding, basic for fiscal 2023 was 144.70M shares, a 0.41% decline from fiscal 2022.
- BIOGEN INC. weighted average number of shares outstanding, basic for fiscal 2022 was 145.30M shares, a 2.55% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 147.20M shares 10-Q · filed 2026-04-29 | 147.00M shares derived: average of 2 quarters · filed 2026-04-29 | 146.87M shares derived: average of 3 quarters · filed 2026-04-29 | 146.78M shares derived: average of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | 146.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | 146.70M shares derived: average of 2 quarters · filed 2026-02-06 | 146.63M shares derived: average of 3 quarters · filed 2026-02-06 | 146.50M shares 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | 146.60M shares 10-Q · filed 2025-10-30 | 146.55M shares derived: average of 2 quarters · filed 2025-10-30 | 146.40M shares 10-Q · filed 2025-10-30 | 146.28M shares derived: average of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | 146.50M shares 10-Q · filed 2025-07-31 | 146.30M shares 10-Q · filed 2025-07-31 | 146.17M shares derived: average of 3 quarters · filed 2026-04-29 | 146.05M shares derived: average of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | 146.10M shares 10-Q · filed 2026-04-29 | 146.00M shares derived: average of 2 quarters · filed 2026-04-29 | 145.90M shares derived: average of 3 quarters · filed 2026-04-29 | 145.82M shares derived: average of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | 145.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | 145.80M shares derived: average of 2 quarters · filed 2026-02-06 | 145.73M shares derived: average of 3 quarters · filed 2026-02-06 | 145.60M shares 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | 145.70M shares 10-Q · filed 2025-10-30 | 145.65M shares derived: average of 2 quarters · filed 2025-10-30 | 145.50M shares 10-Q · filed 2025-10-30 | 145.30M shares derived: average of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | 145.60M shares 10-Q · filed 2025-07-31 | 145.40M shares 10-Q · filed 2025-07-31 | 145.17M shares derived: average of 3 quarters · filed 2026-02-06 | 145.07M shares derived: average of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | 145.20M shares 10-Q · filed 2025-05-01 | 144.95M shares derived: average of 2 quarters · filed 2026-02-06 | 144.90M shares derived: average of 3 quarters · filed 2026-02-06 | 144.85M shares derived: average of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | 144.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | 144.75M shares derived: average of 2 quarters · filed 2026-02-06 | 144.73M shares derived: average of 3 quarters · filed 2026-02-06 | 144.70M shares 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | 144.80M shares 10-Q · filed 2024-10-30 | 144.75M shares derived: average of 2 quarters · filed 2024-10-30 | 144.70M shares 10-Q · filed 2024-10-30 | 144.43M shares derived: average of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | 144.70M shares 10-Q · filed 2024-08-01 | 144.60M shares 10-Q · filed 2024-08-01 | 144.30M shares derived: average of 3 quarters · filed 2025-02-12 | 144.32M shares derived: average of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | 144.40M shares 10-Q · filed 2024-04-24 | 144.10M shares derived: average of 2 quarters · filed 2025-02-12 | 144.20M shares derived: average of 3 quarters · filed 2025-02-12 | 144.63M shares derived: average of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | 143.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | 144.10M shares derived: average of 2 quarters · filed 2025-02-12 | 144.70M shares derived: average of 3 quarters · filed 2025-02-12 | 145.30M shares 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | 144.40M shares 10-Q · filed 2023-11-08 | 145.15M shares derived: average of 2 quarters · filed 2023-11-08 | 145.80M shares 10-Q · filed 2023-11-08 | 146.03M shares derived: average of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | 145.90M shares 10-Q · filed 2023-07-25 | 146.50M shares 10-Q · filed 2023-07-25 | 146.57M shares derived: average of 3 quarters · filed 2024-02-14 | 146.93M shares derived: average of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | 147.10M shares 10-Q · filed 2023-04-25 | 146.90M shares derived: average of 2 quarters · filed 2024-02-14 | 147.27M shares derived: average of 3 quarters · filed 2024-02-14 | 147.88M shares derived: average of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | 146.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | 147.35M shares derived: average of 2 quarters · filed 2024-02-14 | 148.13M shares derived: average of 3 quarters · filed 2024-02-14 | 149.10M shares 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | 148.00M shares 10-Q · filed 2022-10-25 | 148.85M shares derived: average of 2 quarters · filed 2022-10-25 | 149.90M shares 10-Q · filed 2022-10-25 | 150.82M shares derived: average of 4 quarters · filed 2022-10-25 | ||||
| 2021-06-30 | 149.70M shares 10-Q · filed 2022-07-20 | 150.80M shares 10-Q · filed 2022-07-20 | 151.77M shares derived: average of 3 quarters · filed 2022-07-20 | 153.05M shares derived: average of 4 quarters · filed 2022-07-20 | ||||
| 2021-03-31 | 151.90M shares 10-Q · filed 2022-05-03 | 152.80M shares derived: average of 2 quarters · filed 2022-05-03 | 154.17M shares derived: average of 3 quarters · filed 2022-05-03 | 155.78M shares derived: average of 4 quarters · filed 2022-05-03 | ||||
| 2020-12-31 | 153.70M shares 10-K · filed 2021-02-03 | 155.30M shares derived: average of 2 quarters · filed 2021-10-20 | 157.07M shares derived: average of 3 quarters · filed 2021-10-20 | 160.90M shares 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | 156.90M shares 10-Q · filed 2021-10-20 | 158.75M shares derived: average of 2 quarters · filed 2021-10-20 | 163.40M shares 10-Q · filed 2021-10-20 | 167.03M shares derived: average of 4 quarters · filed 2021-10-20 | ||||
| 2020-06-30 | 160.60M shares 10-Q · filed 2021-07-22 | 166.70M shares 10-Q · filed 2021-07-22 | 170.40M shares derived: average of 3 quarters · filed 2021-07-22 | 173.80M shares derived: average of 4 quarters · filed 2021-07-22 | ||||
| 2020-03-31 | 172.80M shares 10-Q · filed 2021-04-22 | 175.30M shares derived: average of 2 quarters · filed 2021-04-22 | 178.20M shares derived: average of 3 quarters · filed 2021-04-22 | 181.22M shares derived: average of 4 quarters · filed 2021-04-22 | ||||
| 2019-12-31 | 177.80M shares 10-K · filed 2021-02-03 | 180.90M shares derived: average of 2 quarters · filed 2021-02-03 | 184.03M shares derived: average of 3 quarters · filed 2021-02-03 | 187.10M shares 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | 184.00M shares 10-K · filed 2021-02-03 | 187.15M shares derived: average of 2 quarters · filed 2021-02-03 | 190.30M shares 10-Q · filed 2020-10-21 | 192.68M shares derived: average of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | 190.30M shares 10-K · filed 2021-02-03 | 193.40M shares 10-Q · filed 2020-07-22 | 195.57M shares derived: average of 3 quarters · filed 2021-02-03 | 197.03M shares derived: average of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | 196.60M shares 10-K · filed 2021-02-03 | 198.20M shares derived: average of 2 quarters · filed 2021-02-03 | 199.27M shares derived: average of 3 quarters · filed 2021-02-03 | 201.22M shares derived: average of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | 199.80M shares 10-K · filed 2020-02-06 | 200.60M shares derived: average of 2 quarters · filed 2020-02-06 | 202.77M shares derived: average of 3 quarters · filed 2020-02-06 | 204.90M shares 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | 201.40M shares 10-K · filed 2020-02-06 | 204.25M shares derived: average of 2 quarters · filed 2020-02-06 | 206.60M shares 10-Q · filed 2019-10-22 | 207.85M shares derived: average of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | 207.10M shares 10-K · filed 2020-02-06 | 209.20M shares 10-Q · filed 2019-07-24 | 210.00M shares derived: average of 3 quarters · filed 2020-02-06 | 210.35M shares derived: average of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | 211.40M shares 10-K · filed 2020-02-06 | 211.45M shares derived: average of 2 quarters · filed 2020-02-06 | 211.43M shares derived: average of 3 quarters · filed 2020-02-06 | 211.55M shares derived: average of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | 211.50M shares 10-K · filed 2019-02-06 | 211.45M shares derived: average of 2 quarters · filed 2019-02-06 | 211.60M shares derived: average of 3 quarters · filed 2019-02-06 | 212.60M shares 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | 211.40M shares 10-K · filed 2019-02-06 | 211.65M shares derived: average of 2 quarters · filed 2019-02-06 | 213.00M shares 10-Q · filed 2018-10-23 | 213.88M shares derived: average of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | 211.90M shares 10-K · filed 2019-02-06 | 213.70M shares 10-Q · filed 2018-07-24 | 214.70M shares derived: average of 3 quarters · filed 2019-02-06 | 215.75M shares derived: average of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | 215.60M shares 10-K · filed 2019-02-06 | 216.10M shares derived: average of 2 quarters · filed 2019-02-06 | 217.03M shares derived: average of 3 quarters · filed 2019-02-06 | 217.55M shares derived: average of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | 216.60M shares 10-K · filed 2018-02-01 | 217.75M shares derived: average of 2 quarters · filed 2018-02-01 | 218.20M shares derived: average of 3 quarters · filed 2018-02-01 | 218.40M shares 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | 218.90M shares 10-K · filed 2018-02-01 | 219.00M shares derived: average of 2 quarters · filed 2018-02-01 | 219.00M shares 10-Q · filed 2017-10-24 | 219.32M shares derived: average of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | 219.10M shares 10-K · filed 2018-02-01 | 219.00M shares 10-Q · filed 2017-07-25 | 219.47M shares derived: average of 3 quarters · filed 2018-02-01 | 222.65M shares derived: average of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | 218.90M shares 10-K · filed 2018-02-01 | 219.65M shares derived: average of 2 quarters · filed 2018-02-01 | 223.83M shares derived: average of 3 quarters · filed 2018-02-01 | 226.70M shares derived: average of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | 220.40M shares 10-K · filed 2017-02-02 | 226.30M shares derived: average of 2 quarters · filed 2017-02-02 | 229.30M shares derived: average of 3 quarters · filed 2017-02-02 | 230.70M shares 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | 232.20M shares 10-K · filed 2017-02-02 | 232.19M shares 10-Q · filed 2015-10-21 | 233.75M shares derived: average of 2 quarters · filed 2017-02-02 | 234.10M shares 10-Q · filed 2016-10-26 | 234.13M shares 10-Q · filed 2015-10-21 | 234.50M shares derived: average of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | 235.30M shares 10-K · filed 2017-02-02 | 235.29M shares 10-Q · filed 2015-07-24 | 235.10M shares 10-Q · filed 2016-07-21 | 235.12M shares 10-Q · filed 2015-07-24 | 235.27M shares derived: average of 3 quarters · filed 2017-02-02 | 235.50M shares derived: average of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | 235.00M shares 10-K · filed 2017-02-02 | 235.00M shares 10-Q · filed 2015-04-24 | 235.25M shares derived: average of 2 quarters · filed 2017-02-02 | 235.57M shares derived: average of 3 quarters · filed 2017-02-02 | 235.85M shares derived: average of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | 235.50M shares 10-K · filed 2016-02-03 | 235.85M shares derived: average of 2 quarters · filed 2016-02-03 | 236.13M shares derived: average of 3 quarters · filed 2016-02-03 | 236.40M shares 10-K · filed 2017-02-02 | 236.36M shares 10-K · filed 2015-02-04 | |||
| 2014-09-30 | 236.20M shares 10-K · filed 2016-02-03 | 236.22M shares 10-Q · filed 2014-10-22 | 236.45M shares derived: average of 2 quarters · filed 2016-02-03 | 236.64M shares 10-Q · filed 2015-10-21 | 236.48M shares derived: average of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | 236.70M shares 10-K · filed 2016-02-03 | 236.66M shares 10-Q · filed 2014-07-23 | 236.73M shares 10-Q · filed 2015-07-24 | 236.57M shares derived: average of 3 quarters · filed 2016-02-03 | 236.69M shares derived: average of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | 236.80M shares 10-K · filed 2016-02-03 | 236.79M shares 10-Q · filed 2014-04-23 | 236.50M shares derived: average of 2 quarters · filed 2016-02-03 | 236.69M shares derived: average of 3 quarters · filed 2016-02-03 | 236.89M shares derived: average of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | 236.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | 236.64M shares derived: average of 2 quarters · filed 2016-02-03 | 236.92M shares derived: average of 3 quarters · filed 2016-02-03 | 236.90M shares 10-K · filed 2016-02-03 | 236.92M shares 10-K · filed 2014-02-06 | |||
| 2013-09-30 | 237.07M shares 10-Q · filed 2014-10-22 | 237.28M shares derived: average of 2 quarters · filed 2014-10-22 | 237.13M shares 10-Q · filed 2014-10-22 | 237.04M shares derived: average of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | 237.48M shares 10-Q · filed 2014-07-23 | 237.16M shares 10-Q · filed 2014-07-23 | 237.03M shares derived: average of 3 quarters · filed 2015-02-04 | 236.89M shares derived: average of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | 236.84M shares 10-Q · filed 2014-04-23 | 236.80M shares derived: average of 2 quarters · filed 2015-02-04 | 236.69M shares derived: average of 3 quarters · filed 2015-02-04 | 237.26M shares derived: average of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | 236.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | 236.62M shares derived: average of 2 quarters · filed 2015-02-04 | 237.41M shares derived: average of 3 quarters · filed 2015-02-04 | 237.94M shares 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | 236.47M shares 10-Q · filed 2013-10-28 | 237.73M shares derived: average of 2 quarters · filed 2013-10-28 | 238.33M shares 10-Q · filed 2013-10-28 | 239.50M shares derived: average of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | 238.99M shares 10-Q · filed 2013-07-25 | 239.39M shares 10-Q · filed 2013-07-25 | 240.51M shares derived: average of 3 quarters · filed 2014-02-06 | 241.10M shares derived: average of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | 239.75M shares 10-Q · filed 2013-04-25 | 241.27M shares derived: average of 2 quarters · filed 2014-02-06 | 241.81M shares derived: average of 3 quarters · filed 2014-02-06 | 241.95M shares derived: average of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | 242.78M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | 242.83M shares derived: average of 2 quarters · filed 2014-02-06 | 242.68M shares derived: average of 3 quarters · filed 2014-02-06 | 242.40M shares 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | 242.88M shares 10-Q · filed 2012-10-25 | 242.63M shares derived: average of 2 quarters · filed 2012-10-25 | 242.27M shares 10-Q · filed 2012-10-25 | 241.57M shares derived: average of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | 242.38M shares 10-Q · filed 2012-07-24 | 241.93M shares 10-Q · filed 2012-07-24 | 241.13M shares derived: average of 3 quarters · filed 2013-02-05 | 240.81M shares derived: average of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | 241.54M shares 10-Q · filed 2012-05-01 | 240.50M shares derived: average of 2 quarters · filed 2013-02-05 | 240.29M shares derived: average of 3 quarters · filed 2013-02-05 | 245.20M shares derived: average of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | 239.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | 239.67M shares derived: average of 2 quarters · filed 2013-02-05 | 246.42M shares derived: average of 3 quarters · filed 2013-02-05 | 252.31M shares 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | 239.86M shares 10-Q · filed 2011-10-28 | 249.90M shares derived: average of 2 quarters · filed 2011-10-28 | 256.59M shares 10-Q · filed 2011-10-28 | 263.48M shares derived: average of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | 259.94M shares 10-Q · filed 2011-07-26 | 265.02M shares 10-Q · filed 2011-07-26 | 271.35M shares derived: average of 3 quarters · filed 2012-02-03 | 275.74M shares derived: average of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | 269.92M shares 10-Q · filed 2011-04-21 | 277.05M shares derived: average of 2 quarters · filed 2012-02-03 | 281.00M shares derived: average of 3 quarters · filed 2012-02-03 | 282.91M shares derived: average of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | 284.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | 286.55M shares derived: average of 2 quarters · filed 2012-02-03 | 287.24M shares derived: average of 3 quarters · filed 2012-02-03 | 287.36M shares 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | 288.92M shares 10-Q · filed 2010-10-26 | 288.77M shares derived: average of 2 quarters · filed 2010-10-26 | 288.42M shares 10-Q · filed 2010-10-26 | 289.18M shares derived: average of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | 288.62M shares 10-Q · filed 2010-07-20 | 288.16M shares 10-Q · filed 2010-07-20 | 289.27M shares derived: average of 3 quarters · filed 2011-02-04 | 289.80M shares derived: average of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | 287.70M shares 10-Q · filed 2010-04-20 | 289.60M shares derived: average of 2 quarters · filed 2011-02-04 | 290.20M shares derived: average of 3 quarters · filed 2011-02-04 | 290.24M shares derived: average of 4 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | 291.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | 291.45M shares derived: average of 2 quarters · filed 2011-02-04 | 291.08M shares derived: average of 3 quarters · filed 2011-02-04 | 292.33M shares 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | 291.41M shares 10-Q · filed 2009-10-21 | 290.88M shares derived: average of 2 quarters · filed 2009-10-21 | 292.61M shares 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | 290.36M shares 10-Q · filed 2009-07-17 | 293.27M shares 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | 315.84M shares 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |